NCT01533480View on ClinicalTrials.gov

A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

April 30, 2016

Conditions
Keratoconjunctivitis Due to AdenovirusViral Shedding
Interventions
DRUG

Zirgan

0.15% ganciclovir gel(Zirgan)

DRUG

genteal gel

0.3% Hypromellose gel

Trial Locations (1)

63017

Lifelong Vision Foundation, Chesterfield

All Listed Sponsors
collaborator

Bausch & Lomb Incorporated

INDUSTRY

lead

Lifelong Vision Foundation

OTHER

NCT01533480 - A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis | Biotech Hunter | Biotech Hunter